Navigation Links
Shire plc: IFRS Results for the Year Ending December 31, 2007
Date:3/25/2008

/p>

Deferred income, current (3.1) 3.1 -

Accrued share based payment

liability (122.9) 122.9 -

______ ___________ ____________

Net assets acquired at fair

value (348.6) 2,351.4 2,002.8

Goodwill 591.7

______ ___________ ____________

2,594.5

Total consideration satisfied

by:

Cash (including US$61.0 million

of direct costs of acquisition) 2,594.5

______ ___________ ____________

Fair value adjustments primarily relate to:

- the recognition of intangible assets totaling US$3,085.8 million, primarily represented by developed technology in respect of VYVANSE for the treatment of ADHD in paediatric patients in the US (US$1,133.3 million) and in-process research and development in respect of VYVANSE for non-paediatric patients in the US and VYVANSE in the RoW (US$1,943.3 million);

- deferred tax liabilities of US$1,110.6 million primarily in respect of temporary differences relating to recognised intangible assets; and

- elimination of liabilities relating to deferred revenue in respect of the New River Collaboration Agree
'/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36%
2. Shire plc: Correction Re Website
3. Shires ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome
4. Shire Engages Palio
5. Texas Boy Receives Wheelchair From New Hampshire Couples Recently Deceased Granddaughter
6. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
7. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
8. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
9. Shire plc: Board Changes
10. David Mott Appointed Non Executive Director at Shire
11. Correction: Shire plc: Third Quarter 2007 results date notification November 1, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... (PRWEB) July 29, 2014 The prestigious ... of Congress was recently awarded to Juliana Hillis and ... MA, for their project, “From an Egg, Everything: America’s ... 3,000 final entries for the National History Day program ... 300 historians and educators in Washington, D.C. , The ...
(Date:7/28/2014)... developed by researchers at the University of Cambridge, could ... realm of science fiction, such as invisibility cloaks and ... a reality for quite some time, the technique which ... a few billionths of a metre across can be ... them, and works on large chunks all at once. ...
(Date:7/28/2014)... July 28, 2014 Proove Biosciences ... will be exhibiting data and research conducted through their ... Spine Intervention Society’s (ISIS) 22nd Annual Scientific Meeting. ... the Hyatt Regency, in Orlando, Florida. , ... clinical competence of physicians who care for patients suffering ...
(Date:7/28/2014)... PA & Boston, MA (PRWEB) July 28, 2014 ... collaboration agreements with two researchers to further develop potential ... deadly malignant brain tumor, in combination with their patented ... by ITI and Duke University, are based on the ... Chief, Division of Neurosurgery at The Preston Robert Tisch ...
Breaking Biology Technology:In Vitro Fertilization (IVF) was the Subject of This Year’s Winning Entry for the Prestigious Library of Congress “Discovery or Exploration in History Award” 2In Vitro Fertilization (IVF) was the Subject of This Year’s Winning Entry for the Prestigious Library of Congress “Discovery or Exploration in History Award” 3Building 'invisible' materials with light 2Proove Biosciences Exhibits Industry Leading Data and Research at International Spine Intervention Society’s 22nd Annual Scientific Meeting 2String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 2String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 3String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 4
... MALVERN, Pa. and SHANGHAI, Feb. 23 Frontage ... of bioanalytical, pre-clinical, clinical and drug development services ... it has expanded its research and development agreement ... of Beijing Pharmaceutical Group ("Beijing Pharma"), to accelerate ...
... WaferGen Biosystems,Inc. (OTC Bulletin Board: WGBS), a ... biology and stem cell research systems, today,announced ... SmartChip Real-Time PCR,System will be presented at ... The data will be presented,by WaferGen ...
... Heart patients with acute coronary syndrome (ACS) undergoing ... option to help prevent heart attacks. Daiichi Sankyo ... (NYSE: LLY ) announced today that the ... (pronounced Ef-ee-ent) (prasugrel) for the prevention ...
Cached Biology Technology:Frontage Laboratories Continues to Grow Its China Business and Add Corporate Financial, Regulatory and Clinical Pharmacology Talent 2Frontage Laboratories Continues to Grow Its China Business and Add Corporate Financial, Regulatory and Clinical Pharmacology Talent 3Frontage Laboratories Continues to Grow Its China Business and Add Corporate Financial, Regulatory and Clinical Pharmacology Talent 4Data on WaferGen's SmartChip Real-Time PCR System(TM) to be Presented at 16th International Molecular Medicine Tri-Conference 2Data on WaferGen's SmartChip Real-Time PCR System(TM) to be Presented at 16th International Molecular Medicine Tri-Conference 3European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI 2European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI 3European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI 4European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI 5
(Date:7/27/2014)... data from over 18,000 patients, scientists have identified ... in Parkinson,s disease, including six that had not ... Nature Genetics , was partially funded by the ... scientists working in NIH laboratories. , "Unraveling the ... the multiple mechanisms involved in this complex disease, ...
(Date:7/25/2014)... lived on the land now called California, and many ... of plants they used for food, fuel, tools, and ... desired habitat and natural resources. , Frank Lake, an ... will lead a field trip to the ... of America,s 99th Annual Meeting, in Sacramento, Cal. this ...
(Date:7/25/2014)... Canadian wildfires have been raging this summer and some of ... U.S. In this image collected by the Moderate Resolution ... 2014 a swath of smoke has descended over the Great ... interesting is the fire image from July 23, 2014 (first ... smoke as it drifts off southeastward. In the image, ...
Breaking Biology News(10 mins):NIH scientists find 6 new genetic risk factors for Parkinson's 2Fire ecology manipulation by California native cultures 2Fire ecology manipulation by California native cultures 3
... to help the government cut through red tape and roll ... This week, the university,s Durham Energy ... meet with the Department of Energy & Climate Change to ... on Wednesday November 3rd will also be attended by Ofgem ...
... Protected areas are generally seen as a triumph for the ... more complex. The world,s largest protected areas encompass vast ... priority areas for conservation or include unusually large numbers of ... the November issue of BioScience . The study, by ...
... and Australia have seen the human immune system,s assassin ... time. The UK team, funded by the Biotechnology and Biological ... based at Birkbeck College where they used powerful electron microscopes ... in rogue cells. The research is published today (1800hrs, 31 ...
Cached Biology News:Durham Energy Institute to advise government on green technology 2Immune system assassin's tricks visualised for the first time 2
Sf21 Insect Cells (Frozen) in Max-XP Medium...
... system, 220-240 V, uses floating pin printing ... lipids, and other biomolecules onto a variety ... can generate high-density arrays with greater than ... than 57,000 spots per membrane with a ...
Freeze 'N Squeeze DNA gel extraction spin columns use a quick freeze-and-thaw cycle and centrifugation to draw 50-23,000 bp DNA out of agarose gel slices. Supplied as 25 columns....
... Storage: The kit is stable for 12 months ... contents of the kit cold. , ,Principle: ... silica-gel based membrane which selectively adsorbs up to ... specialized binding buffers. Nucleotides, oligos ( , ,Application: ...
Biology Products: